Clinical Study of Local and Systemic Biological Impact of GLP1/GIP-Receptor Agonists in Patients With Breast Cancer: The CLARA Trial

NCT07676331 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

168

Enrollment

OTHER

Sponsor class

Conditions

Hormone-receptor-positive Breast Cancer
Early Breast Cancer

Interventions

DRUG: Tirzepatide
DRUG: Letrozole (Aromatase Inhibitors)

Sponsor

Universitaire Ziekenhuizen KU Leuven

Collaborators

[object Object]
[object Object]